macrosporin has been researched along with bakuchiol in 1 studies
| Studies (macrosporin) | Trials (macrosporin) | Recent Studies (post-2010) (macrosporin) | Studies (bakuchiol) | Trials (bakuchiol) | Recent Studies (post-2010) (bakuchiol) |
|---|---|---|---|---|---|
| 9 | 0 | 6 | 131 | 5 | 89 |
| Protein | Taxonomy | macrosporin (IC50) | bakuchiol (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 6.1 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 6.1 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 6.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritz, G; Proksch, P; van Stuijvenberg, J | 1 |
1 other study(ies) available for macrosporin and bakuchiol
| Article | Year |
|---|---|
Targeting the DNA damage response (DDR) by natural compounds.
Topics: Antineoplastic Agents; Biological Products; Cell Proliferation; Cell Survival; Cisplatin; DNA Damage; DNA, Neoplasm; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |